BioCentury
ARTICLE | Company News

Icagen other research news

April 15, 2013 7:00 AM UTC

ICAgen received a $590,000 Phase II SBIR grant from the National Institute of General Medical Sciences to further develop assays that detect drug action at ion channels. Rapid expression cloning of ne...